Global Alzheimer's Drugs Market

the global Alzheimer's drugs market is expected to reach around USD 11.5 Billion in 2032 by growing at a CAGR of 11%. Alzheimer's disease as disease presents a stiff nut to crack in the global health sector given the staggering numbers impacted and the unrelenting way it affects the human brain by causing progressive cognitive impairment. Being a disease that affects the elderly, both in terms of prevalence and incidence, Alzheimer's disease has driven the development of pharmaceutical and healthcare businesses to step up the processes of finding and creating effective medicines to treat it.